An efficient synthesis of N-alkyl-4-substituted 3H-pyridine-2,6-dione. Synthesis of isoguvacine and MDL-11,939

Heterocycles

Volumn 57, Issue 12, 2002, Pages 2321-2334

  Chang, Meng Yang ^a   Chen, Shui Tein ^a   Chang, Nein Chen ^b  

^a INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIARRHYTHMIC AGENT; GLEMANSERIN; GUVACINE DERIVATIVE; PYRIDINE DERIVATIVE;

ARTICLE; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; REACTION ANALYSIS;

EID: 0036900633     PISSN: 03855414     EISSN: None     Source Type: Journal    
DOI: 10.3987/com-02-9620     Document Type: Article

References (30)

1. N. Dawson, W. D. Figg, O. W. Brawley, R. Bergan, M. R. Cooper, A. Senderowicz, D. Headlee, S. M. Steinberg, M. Sutherland, N. Patronas, E. Sausville, W. M. Linehan, E. Reed, and O. Sartor, Chin. Cancer Res., 1998, 4, 37.
2. A. L. Moreia, L. G. Corral, W. Ye, B. A. Johnson, D. Stirling, G. W. Muller, V. H. Freedman, and G. Kaplan, AIDS Res. Hum. Retoviruses, 1997, 13, 857.
3. M. Waelbroeck, S. Lazareno, O. Plaff, T. Friebe, M. Tastoi, E. Mutschler, and G. Lambert, Br. J Pharmacol., 1996, 119, 1319.
4. H. Kiyota, Y. Shimizu, and T. Oritani, Tetrahedron Lett., 2000, 41, 5887.
5. F. Nazar, C. Pham-Huy, and H. Galons, Tetrahedron Lett., 1999, 40, 3697.
6. J. Zhu, C. Pham-Huy, P. Lemoine, A. Tomas, and H. Galons, Heterocycles, 1996, 43, 1923.
7. S. Robin, J. Zhu, H. Galons, C. Pham-Huy, J. R. Claude, A. Tomas, and B. Viossat, Tetrahedron Asymm., 1995, 6, 1249.
8. M. H. Kim and D. V. Patel, Tetrahedron Lett., 1994, 35, 5603.
9. T. Polonski, J. Chem. Soc., Perkin Trans. 1, 1988, 639.
10. C S. Leung, M. G. Rowlands, M. G. Jarman, A. B. Foster, L. J. Griggs, and D. V. R. Wilman, J. Med. Chem., 1987, 30, 1550.
11. T. Kometani, T. Fitz, and D. S. Watt, Tetrahedron Lett., 1986, 27, 919.
12. M. Y. Chang, B. R. Chang, H. M. Tai, and N. C. Chang, Tetrahedron Lett., 2000, 41, 10273.
13. M. Y. Chang, S. T. Chen, and N. C. Chang, Tetrahedron, 2002, 58, 3623.
14. M. Y. Chang, C. H. Chang, S. T. Chen, and N. C. Chang, J. Chin. Chem. Soc., 2002, 49, 383.
15. M. Y. Chang, S. T. Chen, and N. C. Chang, Tetrahedron, 2002, 58, 5075.
16. E. Falch and P. Krogsgaard-Larsen, J. Med. Chem., 1981, 24, 285.
17. A. L. Cambell, D. R. Pilipauskas, I. K. Khanna, and R. A. Rhodes, Tetrahedron Lett., 1987, 28, 2331.
18. M. Rohr, S. Chayer, F. Garrido, A. Mann, M. Taddei, and C.-G. Wermuth, Heterocycles, 1996, 43, 2131.
19. P. Krogsgaard-Larsen, G. A. R. Johnston, D. Lodge, and D. R. Curtis, Nature, 1977, 268, 53.
20. P. Krogsgaard-Larsen, H. Hjeds, D. R. Curtis, D. Lodge, and G. A. R. Johnston, J. Neurochem., 1979, 32, 1717.
21. T. R. Nieduzak and A. A. Carr, Tetrahedron Asymm., 1990, 1, 535.
22. A. A. Carr and N. L. Wiech, US patent 4,783,471, 1988 (Chem. Abstr., 1988, 106, 156281K).
23. D. Lednicer, In The Organic Chemistry of Drug Synthesis; John Wiley & Sons, New York, 1999, pp. 100-101.
24. M. W. Dudley, N. L. Wiech, F. P. Miller, A. A. Carr, H. C. Cheng, L. E. Roebel, N. S. Doherty, H. I. Yamamura, R. C. Ursillo, and M. G. Palfreyman, Drug Development Res., 1988, 13, 29.
25. J. E. Koemer and R. C. Dage, FASEB J., 1989, 3, A1203, 5676.
26. T. Li and R. C. Dage, FASEB J., 1989, 3, A1204, 5677.
27. J. L. Herndon, A. Ismaiel, S. P. Ingher, M. Teitler, and R. A. Glennon, J. Med. Chem., 1992, 35, 4903.
28. A. Ismaiel, K. Arruda, M. Teitler, and R. A. Glennon, J. Med. Chem., 1995, 38, 1196.
29. A. G. Green, A. J. Cross, and G. M. Goodwin, Psychopharmacology, 1995, 119, 247.
30. A. O. Mechan, B. Esteban, E. O'Shea, J. M. Elliott, M. I. Colado, and A. R. Green, Br. J. Pharmacol., 2002, 135, 170.